Standard Lymphoma Therapies Tied to Higher Risk for New Malignancies
Use of high-dose chemotherapy and autologous hematopoietic stem-cell transplantation (HSCT) for patients with aggressive lymphoma was associated with an increased risk of certain second primary malignancies (SPMs), according to a retrospective Danish population-based cohort study. The overall SPM rate was higher among lymphoma patients compared with matched controls from the general population (HR 2.35, 95% […]